SCHEMBL16085406

SCHEMBL16085406

Cc1cccc(Cn2ccc(C(=O)Nc3ncc(Cc4ccc(C(F)(F)F)cc4)s3)n2)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 5/20 0.54
▸ RAB9A P51151 5/20 0.54
▸ MEN1 O00255 4/20 0.54
▸ MAPT P10636 4/20 0.54
▸ KMT2A Q03164 4/20 0.54
▸ KDM4E B2RXH2 3/20 0.54
▸ ALDH1A1 P00352 1/20 0.54
▸ HPGD P15428 1/20 0.54
▸ ABL1 P00519 4/20 0.54
▸ SCD O00767 8/20 0.51
▸ SMN1; SMN2 Q16637 3/20 0.49
▸ LMNA P02545 3/20 0.49
▸ NFKB1 P19838 2/20 0.48
▸ NFKB2 Q00653 2/20 0.48
▸ RELA Q04206 2/20 0.48
▸ GAA P10253 1/20 0.48
▸ CYP1A2 P05177 1/20 0.47
▸ POLB P06746 1/20 0.47
▸ CYP3A4 P08684 1/20 0.47
▸ CYP2D6 P10635 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16085396 0.88 NPC1 (0.46) NPC1RAB9AMEN1MAPTKMT2A
SCHEMBL16085476 0.83 ABL1 (0.47) NPC1RAB9AMEN1MAPTKMT2A
SCHEMBL16085409 0.83 NPC1 (0.45) NPC1RAB9AMEN1MAPTKMT2A
SCHEMBL10299109 0.79 MEN1 (0.59) NPC1RAB9AMEN1MAPTKMT2A
SCHEMBL16085595 0.78 ABL1 (0.50) NPC1RAB9AMEN1MAPTKMT2A
SCHEMBL16085414 0.78 SCD (0.51) NPC1RAB9AMEN1MAPTKMT2A
SCHEMBL16085497 0.76 MAPT (0.61) NPC1RAB9AMEN1MAPTKMT2A
SCHEMBL16085589 0.75 ABL1 (0.47) NPC1RAB9AMEN1MAPTKMT2A
SCHEMBL16085461 0.75 MAPT (0.65) RAB9AMEN1MAPTKMT2AABL1
SCHEMBL16085477 0.74 NR3C1 (0.47) NPC1RAB9AMEN1MAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2014145642-A9 NRF2 SMALL MOLECULE INHIBITORS FOR CANCER THERAPY THE JOHNS HOPKINS UNIVERSITY (US) 2014-11-13 — — WO disclosed
WO-2014145642-A2 NRF2 SMALL MOLECULE INHIBITORS FOR CANCER THERAPY THE JOHNS HOPKINS UNIVERSITY (US) 2014-09-18 — — WO disclosed
Send feedback